Search research articles
Contact Us
Filters
Showing results (511-520 of 537) with videos related to
Page
of 54
Sort By:
Clinical Reviews in Bone and Mineral Metabolism
|
April 2, 2019
Bone Fracture Acute Phase Response-A Unifying Theory of Fracture Repair: Clinical and Scientific Implications
Courtney E Baker, Stephanie N Moore-Lotridge, Alexander A Hysong, et al.
JACC. Basic to Translational Science
|
September 3, 2020
Development of Tissue Engineered Heart Valves for Percutaneous Transcatheter Delivery in a Fetal Ovine Model
Jason Zakko, Kevin M Blum, Joseph D Drews, et al.
Cell Reports
|
November 19, 2013
Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells
Jordan M Blum, Leonor Añó, Zhizhong Li, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
September 19, 2022
Rapid Regeneration of a Neoartery with Elastic Lamellae
Ziyu Wang, Suzanne M Mithieux, Howard Vindin, et al.
Cancer
|
June 23, 2020
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis
Shilpa Grover, Michael Dougan, Kevin Tyan, et al.
Nature Communications
|
March 12, 2024
Tissue engineered vascular grafts are resistant to the formation of dystrophic calcification
Mackenzie E Turner, Kevin M Blum, Tatsuya Watanabe, et al.
Journal for Immunotherapy of Cancer
|
June 10, 2022
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity
Alexander Muik, Homer C Adams 3rd, Friederike Gieseke, et al.
Advanced Healthcare Materials
|
October 16, 2020
Effects of Braiding Parameters on Tissue Engineered Vascular Graft Development
Jacob C Zbinden, Kevin M Blum, Alycia G Berman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 4, 2016
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer
Tanya Stoyanova, Mireille Riedinger, Shu Lin, et al.
Journal for Immunotherapy of Cancer
|
April 11, 2025
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects
Michela Capello, Angelica Sette, Theo Plantinga, et al.
Page
of 54
Search research articles
Search
Showing results (511-520 of 537) with videos related to
Sort By:
Page
of 54
Clinical Reviews in Bone and Mineral Metabolism
|
April 2, 2019
Bone Fracture Acute Phase Response-A Unifying Theory of Fracture Repair: Clinical and Scientific Implications
Courtney E Baker, Stephanie N Moore-Lotridge, Alexander A Hysong, et al.
JACC. Basic to Translational Science
|
September 3, 2020
Development of Tissue Engineered Heart Valves for Percutaneous Transcatheter Delivery in a Fetal Ovine Model
Jason Zakko, Kevin M Blum, Joseph D Drews, et al.
Cell Reports
|
November 19, 2013
Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells
Jordan M Blum, Leonor Añó, Zhizhong Li, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
September 19, 2022
Rapid Regeneration of a Neoartery with Elastic Lamellae
Ziyu Wang, Suzanne M Mithieux, Howard Vindin, et al.
Cancer
|
June 23, 2020
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis
Shilpa Grover, Michael Dougan, Kevin Tyan, et al.
Nature Communications
|
March 12, 2024
Tissue engineered vascular grafts are resistant to the formation of dystrophic calcification
Mackenzie E Turner, Kevin M Blum, Tatsuya Watanabe, et al.
Journal for Immunotherapy of Cancer
|
June 10, 2022
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity
Alexander Muik, Homer C Adams 3rd, Friederike Gieseke, et al.
Advanced Healthcare Materials
|
October 16, 2020
Effects of Braiding Parameters on Tissue Engineered Vascular Graft Development
Jacob C Zbinden, Kevin M Blum, Alycia G Berman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 4, 2016
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer
Tanya Stoyanova, Mireille Riedinger, Shu Lin, et al.
Journal for Immunotherapy of Cancer
|
April 11, 2025
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects
Michela Capello, Angelica Sette, Theo Plantinga, et al.
Page
of 54